dual-specific antibody

AstraZeneca Joins Obesity Market with $30m Investment

📢 Swiss obesity start-up SixPeaks Bio secures $30m, partners with AstraZeneca to develop potential obesity treatment. 💪💊🍔 ObesityMarket Collaboration